CY1511A - Parenteral dezocine compositions - Google Patents
Parenteral dezocine compositionsInfo
- Publication number
- CY1511A CY1511A CY1511A CY151185A CY1511A CY 1511 A CY1511 A CY 1511A CY 1511 A CY1511 A CY 1511A CY 151185 A CY151185 A CY 151185A CY 1511 A CY1511 A CY 1511A
- Authority
- CY
- Cyprus
- Prior art keywords
- dezocine
- vol
- percent
- parenteral
- compositions
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B61—RAILWAYS
- B61K—AUXILIARY EQUIPMENT SPECIALLY ADAPTED FOR RAILWAYS, NOT OTHERWISE PROVIDED FOR
- B61K9/00—Railway vehicle profile gauges; Detecting or indicating overheating of components; Apparatus on locomotives or cars to indicate bad track sections; General design of track recording vehicles
- B61K9/08—Measuring installations for surveying permanent way
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Laminated Bodies (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65597684A | 1984-09-28 | 1984-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1511A true CY1511A (en) | 1990-08-03 |
Family
ID=24631145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1511A CY1511A (en) | 1984-09-28 | 1985-08-27 | Parenteral dezocine compositions |
Country Status (20)
Country | Link |
---|---|
US (1) | US4605671A (ko) |
EP (1) | EP0180303B1 (ko) |
JP (1) | JPH0621060B2 (ko) |
KR (1) | KR890000905B1 (ko) |
AT (1) | ATE41602T1 (ko) |
AU (1) | AU572689B2 (ko) |
CA (1) | CA1251402A (ko) |
CY (1) | CY1511A (ko) |
DE (1) | DE3568942D1 (ko) |
DK (1) | DK165439C (ko) |
GB (1) | GB2165149B (ko) |
HK (1) | HK19990A (ko) |
HU (1) | HU197667B (ko) |
IE (1) | IE58139B1 (ko) |
IL (1) | IL76393A (ko) |
MY (1) | MY102521A (ko) |
NZ (1) | NZ213573A (ko) |
PH (1) | PH20498A (ko) |
SG (1) | SG71489G (ko) |
ZA (1) | ZA856680B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8802564D0 (sv) * | 1988-07-08 | 1988-07-08 | Astra Ab | New synergistic preparations and a new method of alleviation of pain |
IT1302682B1 (it) * | 1998-10-16 | 2000-09-29 | Formenti Farmaceutici Spa | Composizioni farmaceutiche orali contenenti buprenorfina |
CN104523584B (zh) * | 2014-12-22 | 2018-03-30 | 扬子江药业集团有限公司 | 一种地佐辛的注射剂及其制备方法 |
CN106880586A (zh) * | 2015-12-16 | 2017-06-23 | 天津泰普药品科技发展有限公司 | 一种稳定的地佐辛注射剂的制备方法 |
CN110483315B (zh) * | 2018-05-15 | 2021-11-09 | 扬子江药业集团有限公司 | 一种地佐辛杂质c的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4150147A (en) * | 1978-03-24 | 1979-04-17 | American Home Products Corporation | Stimulation of prolactin release by an aminotetralin analgesic |
-
1985
- 1985-07-23 US US06/757,992 patent/US4605671A/en not_active Expired - Lifetime
- 1985-08-27 GB GB08521303A patent/GB2165149B/en not_active Expired
- 1985-08-27 AT AT85306052T patent/ATE41602T1/de not_active IP Right Cessation
- 1985-08-27 EP EP85306052A patent/EP0180303B1/en not_active Expired
- 1985-08-27 DE DE8585306052T patent/DE3568942D1/de not_active Expired
- 1985-08-27 CY CY1511A patent/CY1511A/xx unknown
- 1985-08-28 IE IE211785A patent/IE58139B1/en not_active IP Right Cessation
- 1985-08-30 ZA ZA856680A patent/ZA856680B/xx unknown
- 1985-09-06 AU AU47136/85A patent/AU572689B2/en not_active Expired
- 1985-09-13 IL IL76393A patent/IL76393A/xx not_active IP Right Cessation
- 1985-09-16 CA CA000490818A patent/CA1251402A/en not_active Expired
- 1985-09-20 NZ NZ213573A patent/NZ213573A/xx unknown
- 1985-09-26 KR KR1019850007100A patent/KR890000905B1/ko not_active IP Right Cessation
- 1985-09-27 JP JP60216078A patent/JPH0621060B2/ja not_active Expired - Lifetime
- 1985-09-27 DK DK438785A patent/DK165439C/da not_active IP Right Cessation
- 1985-09-27 PH PH32860A patent/PH20498A/en unknown
- 1985-09-27 HU HU853745A patent/HU197667B/hu unknown
-
1987
- 1987-08-25 MY MYPI87001455A patent/MY102521A/en unknown
-
1989
- 1989-10-25 SG SG714/89A patent/SG71489G/en unknown
-
1990
- 1990-03-15 HK HK199/90A patent/HK19990A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0180303B1 (en) | 1989-03-22 |
MY102521A (en) | 1992-07-31 |
DK165439C (da) | 1993-04-19 |
IL76393A0 (en) | 1986-01-31 |
PH20498A (en) | 1987-01-21 |
GB2165149B (en) | 1988-05-25 |
KR860002269A (ko) | 1986-04-24 |
EP0180303A1 (en) | 1986-05-07 |
NZ213573A (en) | 1988-07-28 |
ZA856680B (en) | 1987-04-29 |
CA1251402A (en) | 1989-03-21 |
US4605671A (en) | 1986-08-12 |
DE3568942D1 (en) | 1989-04-27 |
JPS6185314A (ja) | 1986-04-30 |
IL76393A (en) | 1988-06-30 |
GB2165149A (en) | 1986-04-09 |
DK438785D0 (da) | 1985-09-27 |
IE58139B1 (en) | 1993-07-14 |
IE852117L (en) | 1986-03-28 |
JPH0621060B2 (ja) | 1994-03-23 |
KR890000905B1 (ko) | 1989-04-13 |
HK19990A (en) | 1990-03-23 |
SG71489G (en) | 1990-03-02 |
AU572689B2 (en) | 1988-05-12 |
AU4713685A (en) | 1986-04-10 |
DK438785A (da) | 1986-03-29 |
HU197667B (en) | 1989-05-29 |
HUT39359A (en) | 1986-09-29 |
DK165439B (da) | 1992-11-30 |
ATE41602T1 (de) | 1989-04-15 |
GB8521303D0 (en) | 1985-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT44438A (en) | Composition comprising l-dopa | |
ES8702141A1 (es) | Procedimiento para preparar una dispersion solida de una dishidropiridina farmacologicamente activa en una matriz cristalina como vehiculo. | |
DE3568942D1 (en) | Parenteral composition | |
EP0253143A3 (en) | Pharmaceutical compositions for suppository | |
IL83086A0 (en) | Stable,injectable solutions of vinca dimer salts | |
AU578065B2 (en) | Stabilized enzyme conjugate compositions | |
IE882836L (en) | Antiviral preparations | |
GR3006748T3 (ko) | ||
GR3007793T3 (ko) | ||
PH24913A (en) | Permeation enhancement composition | |
GB8309898D0 (en) | Amine oxide formulations | |
AU557034B2 (en) | 3,5-diphenyl-1h-1,2,4-trazoles with contragestational | |
DE3262234D1 (en) | Pharmaceutical compositions with antalgic effect |